PGNX

Progenics Pharmaceuticals Inc
PGNX

Delisted

PGNX was delisted on the 19th of June, 2020.

142 hedge funds and large institutions have $415M invested in Progenics Pharmaceuticals Inc in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 47 increasing their positions, 43 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
142
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.69M
Puts
$1.16M
Net Calls
Net Calls Change

Top Buyers

1 +$8.28M
2 +$6.05M
3 +$4.42M
4
Nuveen Asset Management
Nuveen Asset Management
Illinois
+$3.92M
5
JGC
J. Goldman & Co
New York
+$2.47M

Top Sellers

1 -$4.73M
2 -$3.88M
3 -$3.73M
4
Citadel Advisors
Citadel Advisors
Florida
-$2.84M
5
Wells Fargo
Wells Fargo
California
-$2.83M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$100K
102
$97K
103
$96K
104
$84K
105
$80K
106
$76K
107
$72K
108
$72K
109
$67K
110
$62K
111
$62K
112
$62K
113
$57.5K
114
$49K
115
$46K
116
$40K
117
$36K
118
$35K
119
$30K
120
$27K
121
$20K
122
$19K
123
$15K
124
$14K
125
$10K